Fundai

Sobhan Darou Company (DSOBHAN) income statement

Operating revenue through to net profit and earnings per share

Ticker
DSOBHAN
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Operating revenue62,538,65820,798,31413,433,30515,907,7178,702,7925,529,916
Cost of operating revenue-19,963,494-11,119,200-8,230,858-8,658,318-4,264,772-2,996,198
Gross profit (loss)42,575,1649,679,1145,202,4477,249,3994,438,0202,533,718
Selling, general and administrative expenses-1,922,120-1,051,974-801,495-624,549-379,373-232,963
Other income100,73528,46455,89134,00766,63319,542
Other expenses-387,085-357,263-211,697-13,259-107,664-42,183
Operating profit (loss)40,366,6948,298,3414,245,1466,645,5983,994,1722,278,114
Finance costs-4,126,354-4,277,989-2,996,908-1,669,344-751,893-391,871
Other non-operating income and expenses1,149,956489,8831,651,701527,639101,795139,442
Profit (loss) from continuing operations before tax37,390,2964,510,2352,899,9395,503,8933,344,0742,025,685
Current year tax-7,932,710-874,4760-849,165-752,416-422,467
Net profit (loss) from continuing operations29,457,5863,635,7592,899,9394,654,7282,591,6581,603,218
Net profit (loss)29,457,5863,635,7592,899,9394,654,7282,591,6581,603,218
Basic earnings (loss) per share2,956 rials534 rials427 rials876 rials714 rials1,150 rials
Net earnings (loss) per share, rials2,946 rials364 rials426 rials874 rials714 rials1,048 rials
Capital10,000,00010,000,0006,820,0005,330,0003,630,0001,530,000

Reporting periods

74 periods are on file for this report, from the period ending 1389/12/29 to the period ending 1405/06/31.